IZANA BIOSCIENCE LIMITED

Dissolved London

Research and experimental development on biotechnology

2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
I

IZANA BIOSCIENCE LIMITED

Research and experimental development on biotechnology

Founded 26 May 2017 Dissolved London, United Kingdom 2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 22 Nov 2024 Next due 31 Dec 2025 5 months overdue
Confirmation Submitted 30 May 2025 Next due 8 Jun 2026 1 month remaining
Net assets £90K £4M 2023 year on year
Total assets £129K £5M 2023 year on year
Total Liabilities £40K £880K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

7th Floor 50 Broadway London SW1H 0DB United Kingdom

Website

www.example.com

Full company profile for IZANA BIOSCIENCE LIMITED (10791466), a dissolved life sciences and medical technology company based in London, United Kingdom. Incorporated 26 May 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Balance Sheet & P&L (2017–2023)

Cash in Bank

£127.15k

Increased by £102.42k (+414%)

Net Assets

£89.74k

Decreased by £4.34M (-98%)

Total Liabilities

£39.53k

Decreased by £879.51k (-96%)

Turnover

N/A

Employees

2

Debt Ratio

31%

Increased by 14 (+82%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 2Dec 2017Strategic Investment

Officers

Officers

1 active 2 resigned
Status
Moore, Lee FrancisDirectorBritishUnited Kingdom455 Aug 2022Active

Shareholders

Shareholders (2)

Kinevant Ltd.
100.0%
Roivant Sciences Ltd.
0.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased

Roivant Sciences Ltd.

Bermuda

Active
Notified 1 Oct 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Zenios Bioscience Llp

Ceased 20 Jul 2020

Ceased

Bryan Morton

Ceased 1 Nov 2017

Ceased

Someit Sidhu

Ceased 1 Nov 2017

Ceased

Group Structure

Group Structure

IZANA BIOSCIENCE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Mar 2026GazetteGazette Dissolved Voluntary
30 May 2025Confirmation StatementConfirmation statement made on 25 May 2025 with no updates
22 Nov 2024AccountsAnnual accounts made up to 31 Mar 2024
6 Jun 2024Confirmation StatementConfirmation statement made on 25 May 2024 with updates
28 Mar 2024CapitalStatement by Directors
24 Mar 2026 Gazette

Gazette Dissolved Voluntary

30 May 2025 Confirmation Statement

Confirmation statement made on 25 May 2025 with no updates

22 Nov 2024 Accounts

Annual accounts made up to 31 Mar 2024

6 Jun 2024 Confirmation Statement

Confirmation statement made on 25 May 2024 with updates

28 Mar 2024 Capital

Statement by Directors

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 months ago on 24 Mar 2026

Confirmation statement made on 25 May 2025 with no updates

11 months ago on 30 May 2025

Annual accounts made up to 31 Mar 2024

1 years ago on 22 Nov 2024

Confirmation statement made on 25 May 2024 with updates

1 years ago on 6 Jun 2024

Statement by Directors

2 years ago on 28 Mar 2024